HYDROMORPHONE HYDROCHLORIDE INJECTION, USP

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: b5d6d2e1fe70694d
Drug Approval Canada Name: HYDROMORPHONE HYDROCHLORIDE INJECTION, USP
Product Name: HYDROMORPHONE HYDROCHLORIDE INJECTION, USP
Status: Marketed
Status Date: 2020-11-10
Original Market Date: 2020-11-10
Din: 02491699
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous , Intramuscular , Intravenous
Schedule: Narcotic (CDSA I)
Ahfs: 28:08.08
Atc Original: N02AA03 HYDROMORPHONE
Atc Name: n 02 aa 03
Aig Number: 0108698003
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

HYDROMORPHONE HYDROCHLORIDE

2 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b5d6d2e1fe70694d

Type

Standard